Related Experiment Video

Updated: Jun 26, 2026

Insertion, Maintenance, and Removal of the Percutaneous Dual Lumen Cannula Right Ventricular Assist Device
07:41

Insertion, Maintenance, and Removal of the Percutaneous Dual Lumen Cannula Right Ventricular Assist Device

Published on: July 20, 2022

1.9K

Patency of Drug-Coated versus Conventional Balloon Angioplasty for Hemodialysis Access Stenosis

Thanawat Anukanchanavera1, Keerati Hongsakul1, Phurich Janjindamai1

  • 1Prince of Songkla University, Thailand.

Journal of the Belgian Society of Radiology
|December 25, 2023
PubMed

Insights

Drug-coated balloon angioplasty (DCBA) demonstrates superior post-intervention target primary patency compared to conventional balloon angioplasty (CBA) for treating dysfunctional arteriovenous fistulas (AVF). This real-world study confirms DCBA as a beneficial option for maintaining fistula patency in hemodialysis patients.

Area of Science:

  • Vascular Surgery
  • Interventional Nephrology
  • Biomedical Engineering

Background:

  • Dysfunctional autogenous arteriovenous fistulas (AVFs) are a significant challenge in hemodialysis access.
  • Maintaining AVF patency is crucial for effective renal replacement therapy.
  • Endovascular treatments, including conventional balloon angioplasty (CBA) and drug-coated balloon angioplasty (DCBA), are employed to manage AVF dysfunction.

Purpose of the Study:

  • To compare the post-intervention target primary patency of DCBA versus CBA in real-world treatment of dysfunctional autogenous AVFs.
  • To evaluate the effectiveness of DCBA in improving long-term fistula function.

Main Methods:

  • A retrospective study of 24 patients with end-stage renal disease and dysfunctional AVFs undergoing endovascular treatment.
  • Analysis of demographic data, fistula details, and post-intervention target primary patency.
  • Statistical analysis using Weibull proportional hazards regression model.

Main Results:

  • DCBA was identified as a protective factor for treating dysfunctional AVF lesions (adjusted hazard ratio: 0.725, P=0.047).
  • DCBA demonstrated significantly longer post-intervention target primary patency compared to CBA.
  • The study included 333 endovascular treatments across 57 target lesions in 16 men and 8 women.

Conclusions:

  • DCBA offers superior post-intervention target primary patency for dysfunctional autogenous AVFs in a real-world clinical setting.
  • DCBA represents an effective treatment option for improving and maintaining AVF function in hemodialysis patients.
Abstract

Keywords:
conventional balloon angioplastydialysis access stenosisdrug-coated balloon angioplastyend-stage renal diseaseprimary patency

More Related Videos

Reduction of Radiation Exposure during Endovascular Treatment of Peripheral Arterial Disease Combining Fiber Optic RealShape Technology and Intravascular Ultrasound13:48

Reduction of Radiation Exposure during Endovascular Treatment of Peripheral Arterial Disease Combining Fiber Optic RealShape Technology and Intravascular Ultrasound

Published on: April 21, 2023

1.5K
Author Spotlight: Utilizing Venoplasty Balloon Model in Rodents to Simulate Surgical Interventions for Deep Veins05:44

Author Spotlight: Utilizing Venoplasty Balloon Model in Rodents to Simulate Surgical Interventions for Deep Veins

Published on: May 24, 2024

658

Related Concept Videos

Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Hemodialysis I: Introduction01:25

Hemodialysis I: Introduction

Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...
Hemodialysis II: Procedure and Complications01:24

Hemodialysis II: Procedure and Complications

DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...